(Q35986356)

English

Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27067479%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27067479%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

1 reference

based on heuristic

inferred from title

arterial hypertension

1 reference

based on heuristic

inferred from title

Ardeschir Ghofrani

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27067479%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Friedrich Grimminger

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27067479%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27067479%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27067479%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

author name string

Ekkehard Grünig

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27067479%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Yigao Huang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27067479%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Zhi-Cheng Jing

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27067479%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

David Kilpatrick

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27067479%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

David Langleben

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27067479%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Stephan Rosenkranz

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27067479%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Flavia Menezes

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27067479%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Arno Fritsch

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27067479%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Sylvia Nikkho

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27067479%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

publication date

8 April 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27067479%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

The Lancet. Respiratory medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27067479%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27067479%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27067479%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

361-371

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27067479%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary arterial hypertension: epidemiology and registries

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Health-related quality of life in patients with pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Five-Year outcomes of patients enrolled in the REVEAL Registry

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment goals of pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of two predictive models for survival in pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Riociguat for the treatment of pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of clinically relevant responder threshold criteria to evaluate the response to treatment in the phase III PATENT-1 study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A meta-analysis of trials of pulmonary hypertension: a clinical condition looking for drugs and research methodology

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review of trials using vasodilators in pulmonary arterial hypertension: why a new approach is needed

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Do Changes of 6-Minute Walk Distance Predict Clinical Events in Patients With Pulmonary Arterial Hypertension?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Beraprost therapy for pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival with first-line bosentan in patients with primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Macitentan and morbidity and mortality in pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival in patients with pulmonary arterial hypertension treated with first-line bosentan

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Selexipag for the Treatment of Pulmonary Arterial Hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930019-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2213-2600(16)30019-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27067479%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27067479%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35986356&oldid=1969400029"